Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteopetrosis: Pathogenesis, Clinical Management, and Emerging Therapies.

Current osteoporosis reports·2026
Same author

The Importance of Biochemical Screenings in the Diagnosis of Hypophosphatasia: Applications, Methodologies, and Challenges.

International journal of molecular sciences·2026
Same author

Tracking the Photoinduced Dynamics of a Dark Excitonic State in Single-Layer WS_{2} via Resonant Autler-Townes Splitting.

Physical review letters·2026
Same author

Evolving our understanding of vitamin D, periostin levels and cardiovascular risk in the elderly: a cross sectional study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Bone status in patients with chronic hypoparathyroidism: results from the Italian HypoparaNET database.

Aging clinical and experimental research·2025
Same author

Serums miR-24-3p and miR-1301-3p as Potential Biomarkers in MEN1 Syndrome.

International journal of molecular sciences·2025
Same journal

Comparison of adenoma and gland hyperplasia on bone mineral density in primary hyperparathyroidism.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

The influence of pregnancy and selected aspects of female health on skeletal status and fracture incidence in postmenopausal women from the RACOST-POL Study.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

The association of sclerostin with osteoporosis and vertebral fractures in patients with type 2 diabetes mellitus.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

Assessment of bone microarchitecture in postmenopausal women with primary hyperparathyroidism using trabecular bone score.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

Erxian decoction for postmenopausal osteoporosis: An updated systematic review and meta-analysis.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
Same journal

Associations of discordance in hip bone mineral density with hip osteoarthrosis severity and progression to total hip replacement in middle-aged adults.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Hereditary hyperparathyroidism syndromes.

Francesca Giusti1, Loredana Cavalli, Tiziana Cavalli

  • 1Bone and Mineral Metabolism Unit, Department of Internal Medicine, University Hospital of Careggi, Florence, Italy.

Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|February 5, 2013
PubMed
Summary
This summary is machine-generated.

Primary hyperparathyroidism, a common endocrine disorder, is usually sporadic but can be familial. Genetic testing now enables early diagnosis in asymptomatic relatives, improving patient and family management.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Related Experiment Videos

Last Updated: May 14, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Area of Science:

  • Endocrinology
  • Genetics
  • Medical Diagnostics

Background:

  • Primary hyperparathyroidism is a frequent endocrine disorder characterized by hypercalcemia and insufficient parathyroid hormone secretion.
  • While approximately 95% of cases are sporadic, a rare familial form exists, often presenting earlier and affecting both sexes equally.

Purpose of the Study:

  • To highlight the diagnostic challenges in primary hyperparathyroidism.
  • To emphasize the importance of differentiating between sporadic and familial forms for effective patient and family management.
  • To underscore the impact of genetic testing on early diagnosis.

Main Methods:

  • Review of clinical data and family history.
  • Application of specific genetic testing for inherited forms.
  • Differential diagnosis strategies for endocrine disorders.

Main Results:

  • Genetic testing significantly improves diagnostic accuracy for primary hyperparathyroidism.
  • Early diagnosis is now possible in asymptomatic family members.
  • Distinguishing familial from sporadic cases is crucial for management.

Conclusions:

  • Genetic testing represents a major advancement in diagnosing primary hyperparathyroidism.
  • Early identification of familial cases through genetic testing facilitates timely intervention and family screening.
  • Improved diagnostic accuracy enhances the management of patients and their families affected by this endocrine disorder.